DFE Pharma, Harro Höfliger and Sterling Establish Joint Initiative

DFE Pharma (excipients solution provider), Harro Höfliger (equipment supplier), and Sterling (API manufacturer) have partnered to establish “Inhalation Together” (INTO) in the field of dry powder inhalation (DPI).
 
This initiative provides R&D services to pharmaceutical companies in the respiratory field, making formulation development simpler, faster, and easier to manage. INTO offers a coordinated and aligned suite of services, leveraging the expertise and complementary skill sets of its three partners.
 
Developing a DPI formulation is a complex process, with a strong interdependency between process, powder, device and patient. This increases the need for high-quality customer support. To address the specific customer needs, the INTO services range from initial consultancy and problem statement development to a stepwise formulation development program. The individual services include, among others, solid-state characterization and sono-crystallization of APIs and studies to optimize formulation, blending, and filling. The three INTO partners can also offer extensive consultancy services.
 
“I am very excited about the INTO initiative because it increases speed to market and reduces the complexity of formulation and process development. The three companies have a very good understanding of the critical aspects of development and manufacture of DPI products, therefore, adding significant value to our customers,” explained Martti Hedman, CEO of DFE Pharma.